PT  - JOURNAL ARTICLE
AU  - Kilickap, Saadettin
AU  - Sezer, Ahmet
AU  - Gümüş, Mahmut
AU  - Bondarenko, Igor
AU  - Özgüroğlu, Mustafa
AU  - Gogishvili, Miranda
AU  - He, Xuanyao
AU  - Gullo, Giuseppe
AU  - Rietschel, Petra
AU  - Quek, Ruben GW
TI  - 600 Objective response impact on patient reported outcomes (PROs) in patients with aNSCLC with PD-L1 ≥50% receiving cemiplimab versus chemotherapy: EMPOWER-Lung 1
AID  - 10.1136/jitc-2023-SITC2023.0600
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A683--A683
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A683.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A683.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.